Inter‐observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions
暂无分享,去创建一个
J. Naeyaert | G. Piérard | L. Brochez | E. Verhaeghe | Lieve Brochez | E. Grosshans | E. Haneke | D. Ruiter | Jean-Marie Naeyaert | Evelien Verhaeghe | Edouard Grosshans | Eckhart Haneke | Gérald Piérard | Dirk Ruiter
[1] Martin F. Mihm,et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma , 2000, Cancer.
[2] M. Mihm,et al. Recognition and evaluation of cytological dysplasia in acquired melanocytic nevi. , 1999, Human pathology.
[3] M. Mihm,et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. , 1999, Human pathology.
[4] E. Kay,et al. Identification of vertical growth phase in malignant melanoma. A study of interobserver agreement. , 1998, American journal of clinical pathology.
[5] J. Hunter,et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94 , 1997, BMJ.
[6] S. Cramer. Interobserver variability in dermatopathology. , 1997, Archives of dermatology.
[7] T. McCalmont. Melanoma and melanoma in situ: build a better diagnosis through architecture. , 1997, Seminars in cutaneous medicine and surgery.
[8] R. Marks,et al. Who removes pigmented skin lesions? , 1997, Journal of the American Academy of Dermatology.
[9] S. Humphreys,et al. A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel. , 1997, Journal of Clinical Pathology.
[10] R. Marks. The 19th World Congress of Dermatology, Sydney, Australia, June 15-21, 1997. Look back! Look around! Look forward! , 1997, Journal of the American Academy of Dermatology.
[11] E. Farmer,et al. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. , 1996, Human pathology.
[12] S. Humphreys,et al. The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel , 1996, Histopathology.
[13] M. Skolnick,et al. Interobserver concordance in discriminating clinical atypia of melanocytic nevi, and correlations with histologic atypia. , 1996, Journal of the American Academy of Dermatology.
[14] R. Corona,et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] R. Swerlick,et al. The melanoma epidemic. Is increased surveillance the solution or the problem? , 1996, Archives of dermatology.
[16] P. Andersen,et al. Observer variation in histological classification of cutaneous malignant melanoma. , 1995, Scandinavian journal of plastic and reconstructive surgery and hand surgery.
[17] W. Clark,et al. Inter-observer variability among pathologists' evaluation of malignant melanoma: effects upon an analytic study. , 1994, Journal of clinical epidemiology.
[18] U. Ringborg,et al. Prognostic factors in thin cutaneous malignant melanoma , 1994, Cancer.
[19] C. Lewis,et al. A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. , 1994, Journal of the American Academy of Dermatology.
[20] N. Dubin,et al. Prediction of histologic melanocytic dysplasia from clinical observation. , 1993, Journal of the American Academy of Dermatology.
[21] D. Elder,et al. Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. , 1993, The Journal of investigative dermatology.
[22] M. Mihm,et al. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. , 1993, The Journal of investigative dermatology.
[23] D. Ruiter,et al. Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. , 1993, European journal of cancer.
[24] R. Dersimonian,et al. An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions. , 1992, Journal of the American Academy of Dermatology.
[25] L. M. Roth,et al. The mystique of the mistake. With proposed standards for validating proficiency tests in anatomic pathology. , 1991, American journal of clinical pathology.
[26] L. McWilliam,et al. Performance of skin biopsies by general practitioners. , 1991, BMJ.
[27] Allen Caldwell,et al. Panel , 1991, 2021 IEEE International Conference on Pervasive Computing and Communications (PerCom).
[28] A. Ackerman. Histologic atypia in clinically benign nevi. , 1991, Journal of the American Academy of Dermatology.
[29] D. Elder,et al. Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. , 1991, Human pathology.
[30] J. Davies,et al. Measurement techniques for melanoma: a statistical comparison , 1991, Journal of clinical pathology.
[31] P. Colloby,et al. Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma , 1991, The Journal of pathology.
[32] M. Piepkorn. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi. , 1990, Archives of dermatology.
[33] R. Barr,et al. Histologic atypia in clinically benign nevi. A prospective study. , 1990, Journal of the American Academy of Dermatology.
[34] J. Bonerandi,et al. Dysplastic naevus in non‐familial melanoma. A clinicopathological study of 101 cases , 1988, The British journal of dermatology.
[35] D. Ruiter,et al. The efficacy of histopathological criteria required for diagnosing dysplastic naevi , 1988, Histopathology.
[36] M. N. Epstein,et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. , 1984, Human pathology.
[37] C. Holman,et al. Inter‐observer variation between pathologists in the classification of cutaneous malignant melanoma in Western Australia , 1984, Histopathology.
[38] R. Riegelman. Studying a Study and Testing a Test: How to Read the Medical Literature , 1981 .
[39] A. Cochran,et al. Difficulties encountered in the application of clark classification and the Breslow thickness measurement in cutaneous malignant melanoma , 1980, International journal of cancer.